The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Doxorubicin Adverse Reaction|Cardiomyopathies, Secondary|Breast Cancer
Sponsor: Rush University Medical Center